{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T17:24:20Z","timestamp":1773681860886,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,11,19]],"date-time":"2010-11-19T00:00:00Z","timestamp":1290124800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1038\/leu.2010.261","type":"journal-article","created":{"date-parts":[[2010,11,19]],"date-time":"2010-11-19T16:57:54Z","timestamp":1290185874000},"page":"331-340","source":"Crossref","is-referenced-by-count":21,"title":["Selective killing of Burkitt's lymphoma cells by mBAFF-targeted delivery of PinX1"],"prefix":"10.1038","volume":"25","author":[{"given":"L","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,11,19]]},"reference":[{"key":"BFleu2010261_CR1","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1158\/1535-7163.MCT-06-0254","volume":"6","author":"MA Lyu","year":"2007","unstructured":"Lyu MA, Cheung LH, Hittelman WN, Marks JW, Aguiar RC, Rosenblum MG . The rGel\/BLyS fusion toxin specifically targets malignant B cells expressing the BLyS receptors BAFF-R, TACI, and BCMA. Mol Cancer Ther 2007; 6: 460\u2013470.","journal-title":"Mol Cancer Ther"},{"key":"BFleu2010261_CR2","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1182\/blood-2006-08-042424","volume":"109","author":"R Nimmanapalli","year":"2007","unstructured":"Nimmanapalli R, Lyu MA, Du M, Keating MJ, Rosenblum MG, Gandhi V . The growth factor fusion construct containing B-lymphocyte stimulator (BLyS) and the toxin rGel induces apoptosis specifically in BAFF-R-positive CLL cells. Blood 2007; 109: 2557\u20132564.","journal-title":"Blood"},{"key":"BFleu2010261_CR3","doi-asserted-by":"publisher","first-page":"11830","DOI":"10.1158\/0008-5472.CAN-07-1160","volume":"67","author":"T Wang","year":"2007","unstructured":"Wang T, Zhao J, Ren JL, Zhang L, Wen WH, Zhang R et al. Recombinant immunoproapoptotic proteins with furin site can translocate and kill HER2-positive cancer cells. Cancer Res 2007; 67: 11830\u201311839.","journal-title":"Cancer Res"},{"key":"BFleu2010261_CR4","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.4161\/cbt.7.8.6261","volume":"7","author":"L Zhang","year":"2008","unstructured":"Zhang L, Zhao J, Wang T, Yu CJ, Jia LT, Duan YY et al. HER2-targeting recombinant protein with truncated pseudomonas exotoxin A translocation domain efficiently kills breast cancer cells. Cancer Biol Ther 2008; 7: 1226\u20131231.","journal-title":"Cancer Biol Ther"},{"key":"BFleu2010261_CR5","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1182\/blood-2004-02-0762","volume":"104","author":"AJ Novak","year":"2004","unstructured":"Novak AJ, Grote DM, Stenson M, Ziesmer SC, Witzig TE, Habermann TM et al. Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome. Blood 2004; 104: 2247\u20132253.","journal-title":"Blood"},{"key":"BFleu2010261_CR6","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1182\/blood-2007-03-077222","volume":"111","author":"RT Woodland","year":"2008","unstructured":"Woodland RT, Fox CJ, Schmidt MR, Hammerman PS, Opferman JT, Korsmeyer SJ et al. Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival. Blood 2008; 111: 750\u2013760.","journal-title":"Blood"},{"key":"BFleu2010261_CR7","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/intimm\/dxm011","volume":"19","author":"BD Hondowicz","year":"2007","unstructured":"Hondowicz BD, Alexander ST, Quinn III WJ, Pagan AJ, Metzgar MH, Cancro MP et al. The role of BLyS\/BLyS receptors in anti-chromatin B cell regulation. Int Immunol 2007; 19: 465\u2013475.","journal-title":"Int Immunol"},{"key":"BFleu2010261_CR8","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/j.1365-2141.2007.06615.x","volume":"137","author":"C Tecchio","year":"2007","unstructured":"Tecchio C, Nadali G, Scapini P, Bonetto C, Visco C, Tamassia N et al. High serum levels of B-lymphocyte stimulator are associated with clinical-pathological features and outcome in classical Hodgkin lymphoma. Br J Haematol 2007; 137: 553\u2013559.","journal-title":"Br J Haematol"},{"key":"BFleu2010261_CR9","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1200\/JCO.2005.02.7938","volume":"24","author":"AJ Novak","year":"2006","unstructured":"Novak AJ, Grote DM, Ziesmer SC, Kline MP, Manske MK, Slager S et al. Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders. J Clin Oncol 2006; 24: 983\u2013987.","journal-title":"J Clin Oncol"},{"key":"BFleu2010261_CR10","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1182\/blood-2003-06-2043","volume":"103","author":"AJ Novak","year":"2004","unstructured":"Novak AJ, Darce JR, Arendt BK, Harder B, Henderson K, Kindsvogel W et al. Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival. Blood 2004; 103: 689\u2013694.","journal-title":"Blood"},{"key":"BFleu2010261_CR11","first-page":"422","volume":"44","author":"TA Riccobene","year":"2003","unstructured":"Riccobene TA, Miceli RC, Lincoln C, Knight Y, Meadows J, Stabin MG et al. Rapid and specific targeting of 125I-labeled B lymphocyte stimulator to lymphoid tissues and B cell tumors in mice. J Nucl Med 2003; 44: 422\u2013433.","journal-title":"J Nucl Med"},{"key":"BFleu2010261_CR12","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0092-8674(02)00631-1","volume":"108","author":"Y Liu","year":"2002","unstructured":"Liu Y, Xu L, Opalka N, Kappler J, Shu HB, Zhang G . Crystal structure of sTALL-1 reveals a virus-like assembly of TNF family ligands. Cell 2002; 108: 383\u2013394.","journal-title":"Cell"},{"key":"BFleu2010261_CR13","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0092-8674(01)00538-4","volume":"107","author":"XZ Zhou","year":"2001","unstructured":"Zhou XZ, Lu KP . The Pin2\/TRF1-interacting protein PinX1 is a potent telomerase inhibitor. Cell 2001; 107: 347\u2013359.","journal-title":"Cell"},{"key":"BFleu2010261_CR14","first-page":"319","volume":"29","author":"M Zavlaris","year":"2009","unstructured":"Zavlaris M, Angelopoulou K, Vlemmas I, Papaioannou N . Telomerase reverse transcriptase (TERT) expression in canine mammary tissues: a specific marker for malignancy? Anticancer Res 2009; 29: 319\u2013325.","journal-title":"Anticancer Res"},{"key":"BFleu2010261_CR15","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3343\/kjlm.2008.28.6.430","volume":"28","author":"YP Park","year":"2008","unstructured":"Park YP, Kim KD, Kang SH, Yoon dY, Park JW, Kim JW et al. Human telomerase reverse transcriptase (hTERT): a target molecule for the treatment of cisplatin-resistant tumors. Korean J Lab Med 2008; 28: 430\u2013437.","journal-title":"Korean J Lab Med"},{"key":"BFleu2010261_CR16","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/nsb941","volume":"10","author":"S Henrich","year":"2003","unstructured":"Henrich S, Cameron A, Bourenkov GP, Kiefersauer R, Huber R, Lindberg I et al. The crystal structure of the proprotein processing proteinase furin explains its stringent specificity. Nat Struct Biol 2003; 10: 520\u2013526.","journal-title":"Nat Struct Biol"},{"key":"BFleu2010261_CR17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.canlet.2008.04.024","volume":"269","author":"L Zhang","year":"2008","unstructured":"Zhang L, Gao H, Chen L, Wu B, Zheng Y, Liao R et al. Tumor targeting of vincristine by mBAFF-modified PEG liposomes in B lymphoma cells. Cancer Lett 2008; 269: 26\u201336.","journal-title":"Cancer Lett"},{"key":"BFleu2010261_CR18","first-page":"5876","volume":"51","author":"MA Ghetie","year":"1991","unstructured":"Ghetie MA, Richardson J, Tucker T, Jones D, Uhr JW, Vitetta ES . Antitumor activity of Fab\u2019 and IgG-anti-CD22 immunotoxins in disseminated human B lymphoma grown in mice with severe combined immunodeficiency disease: effect on tumor cells in extranodal sites. Cancer Res 1991; 51: 5876\u20135880.","journal-title":"Cancer Res"},{"key":"BFleu2010261_CR19","first-page":"1505","volume":"7","author":"R Ochakovskaya","year":"2001","unstructured":"Ochakovskaya R, Osorio L, Goldenberg DM, Mattes MJ . Therapy of disseminated B-cell lymphoma xenografts in severe combined immunodeficient mice with an anti-CD74 antibody conjugated with (111)indium, (67)gallium, or (90)yttrium. Clin Cancer Res 2001; 7: 1505\u20131510.","journal-title":"Clin Cancer Res"},{"key":"BFleu2010261_CR20","doi-asserted-by":"publisher","first-page":"9221","DOI":"10.1073\/pnas.0904140106","volume":"106","author":"EO Serebrovskaya","year":"2009","unstructured":"Serebrovskaya EO, Edelweiss EF, Stremovskiy OA, Lukyanov KA, Chudakov DM, Deyev SM . Targeting cancer cells by using an antireceptor antibody-photosensitizer fusion protein. Proc Natl Acad Sci USA 2009; 106: 9221\u20139225.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2010261_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1159\/000188665","volume":"76","author":"HK Vyas","year":"2009","unstructured":"Vyas HK, Pal R, Vishwakarma R, Lohiya NK, Talwar GP . Selective killing of leukemia and lymphoma cells ectopically expressing hCGbeta by a conjugate of curcumin with an antibody against hCGbeta subunit. Oncology 2009; 76: 101\u2013111.","journal-title":"Oncology"},{"key":"BFleu2010261_CR22","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1158\/0008-5472.CAN-04-2594","volume":"65","author":"AJ Marks","year":"2005","unstructured":"Marks AJ, Cooper MS, Anderson RJ, Orchard KH, Hale G, North JM et al. Selective apoptotic killing of malignant hemopoietic cells by antibody-targeted delivery of an amphipathic peptide. Cancer Res 2005; 65: 2373\u20132377.","journal-title":"Cancer Res"},{"key":"BFleu2010261_CR23","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.1182\/blood-2008-08-173195","volume":"113","author":"JE Weldon","year":"2009","unstructured":"Weldon JE, Xiang L, Chertov O, Margulies I, Kreitman RJ, FitzGerald DJ et al. A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicity. Blood 2009; 113: 3792\u20133800.","journal-title":"Blood"},{"key":"BFleu2010261_CR24","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1182\/blood-2003-02-0540","volume":"103","author":"C Kern","year":"2004","unstructured":"Kern C, Cornuel JF, Billard C, Tang R, Rouillard D, Stenou V et al. Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway. Blood 2004; 103: 679\u2013688.","journal-title":"Blood"},{"key":"BFleu2010261_CR25","doi-asserted-by":"publisher","first-page":"8285","DOI":"10.1074\/jbc.M412430200","volume":"280","author":"H Michiue","year":"2005","unstructured":"Michiue H, Tomizawa K, Wei FY, Matsushita M, Lu YF, Ichikawa T et al. The NH2 terminus of influenza virus hemagglutinin-2 subunit peptides enhances the antitumor potency of polyarginine-mediated p53 protein transduction. J Biol Chem 2005; 280: 8285\u20138289.","journal-title":"J Biol Chem"},{"key":"BFleu2010261_CR26","doi-asserted-by":"publisher","first-page":"10540","DOI":"10.1074\/jbc.M510026200","volume":"281","author":"MS Sutherland","year":"2006","unstructured":"Sutherland MS, Sanderson RJ, Gordon KA, Andreyka J, Cerveny CG, Yu C et al. Lysosomal trafficking and cysteine protease metabolism confer target-specific cytotoxicity by peptide-linked anti-CD30-auristatin conjugates. J Biol Chem 2006; 281: 10540\u201310547.","journal-title":"J Biol Chem"},{"key":"BFleu2010261_CR27","first-page":"6567","volume":"9","author":"GL Griffiths","year":"2003","unstructured":"Griffiths GL, Mattes MJ, Stein R, Govindan SV, Horak ID, Hansen HJ et al. Cure of SCID mice bearing human B-lymphoma xenografts by an anti-CD74 antibody-anthracycline drug conjugate. Clin Cancer Res 2003; 9: 6567\u20136571.","journal-title":"Clin Cancer Res"},{"key":"BFleu2010261_CR28","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.4049\/jimmunol.172.5.3268","volume":"172","author":"B He","year":"2004","unstructured":"He B, Chadburn A, Jou E, Schattner EJ, Knowles DM, Cerutti A . Lymphoma B cells evade apoptosis through the TNF family members BAFF\/BLyS and APRIL. J Immunol 2004; 172: 3268\u20133279.","journal-title":"J Immunol"},{"key":"BFleu2010261_CR29","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1007\/s12185-010-0567-z","volume":"91","author":"K Onda","year":"2010","unstructured":"Onda K, Iijima K, Katagiri YU, Okita H, Saito M, Shimizu T et al. Differential effects of BAFF on B cell precursor acute lymphoblastic leukemia and Burkitt lymphoma. Int J Hematol 2010; 91: 808\u2013819.","journal-title":"Int J Hematol"},{"key":"BFleu2010261_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1471-2407-9-83","volume":"9","author":"J Moreaux","year":"2009","unstructured":"Moreaux J, Veyrune JL, De Vos J, Klein B . APRIL is overexpressed in cancer: link with tumor progression. BMC Cancer 2009; 9: 83.","journal-title":"BMC Cancer"},{"key":"BFleu2010261_CR31","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1056\/NEJMoa055759","volume":"354","author":"SS Dave","year":"2006","unstructured":"Dave SS, Fu K, Wright GW, Lam LT, Kluin P, Boerma EJ et al. Molecular diagnosis of Burkitt's lymphoma. N Engl J Med 2006; 354: 2431\u20132442.","journal-title":"N Engl J Med"},{"key":"BFleu2010261_CR32","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1159\/000082107","volume":"8","author":"DF Jelinek","year":"2005","unstructured":"Jelinek DF, Darce JR . Human B lymphocyte malignancies: exploitation of BLyS and APRIL and their receptors. Curr Dir Autoimmun 2005; 8: 266\u2013288.","journal-title":"Curr Dir Autoimmun"},{"key":"BFleu2010261_CR33","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.humpath.2003.07.009","volume":"34","author":"KC Chiu","year":"2003","unstructured":"Chiu KC, Fine M, Ikle D, Slovak ML, Arber DA . Telomerase activity and proliferation index in aggressive mature B-cell lymphoma: comparison to germinal center phenotypic markers. Hum Pathol 2003; 34: 1259\u20131264.","journal-title":"Hum Pathol"},{"key":"BFleu2010261_CR34","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood.V89.1.26","volume":"89","author":"P Brousset","year":"1997","unstructured":"Brousset P, al Saati T, Chaouche N, Zenou RC, Schlaifer D, Chittal S et al. activity in reactive and neoplastic lymphoid tissues: infrequent detection of activity in Hodgkin's disease. Blood 1997; 89: 26\u201331.","journal-title":"Blood"},{"key":"BFleu2010261_CR35","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1046\/j.1523-5394.1998.006003195.x","volume":"6","author":"SD Scott","year":"1998","unstructured":"Scott SD . Rituximab: a new therapeutic monoclonal antibody for non-Hodgkin's lymphoma. Cancer Pract 1998; 6: 195\u2013197.","journal-title":"Cancer Pract"},{"key":"BFleu2010261_CR36","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/1097-0142(20000715)89:2<445::AID-CNCR33>3.0.CO;2-T","volume":"89","author":"SA Ely","year":"2000","unstructured":"Ely SA, Chadburn A, Dayton CM, Cesarman E, Knowles DM . Telomerase activity in B-cell non-Hodgkin lymphoma. Cancer 2000; 89: 445\u2013452.","journal-title":"Cancer"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/leu2010261.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/leu2010261","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/leu2010261.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:03:19Z","timestamp":1684432999000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2010261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,19]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["BFleu2010261"],"URL":"https:\/\/doi.org\/10.1038\/leu.2010.261","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,19]]}}}